Report Sets the Stage for Molecular Oncology and Genetic Testing Across
OntarioTORONTO, Jan. 23 /CNW/ - Cancer Care Ontario's (CCO) Molecular Oncology
Task Force will release its first report which describes the current state and
makes recommendations on improving access to and quality of genetic testing in
Ontario to keep pace with advancing technologies in this field.
Speakers will discuss advances in this field, the response required by
the health care system and a cancer patient's personal experience on how
genetic testing affected their cancer journey.Speakers:
- Dr. Mary Gospodarowicz, Regional Vice President, Toronto Central
Regional Cancer Program, CCO and Medical Director, Cancer Program,
Princess Margaret Hospital, University Health Network
- Terrence Sullivan, President and CEO, CCO
- Mr. Richard Field, Cancer Patient
- Dr. Suzanne Kamel-Reid, Chair, Molecular Oncology Task Force and Co-
Chair, Lab Services, CCO, Head of Laboratory Genetics and Director,
Molecular Diagnostics, University Health Network, Ontario Genetics
Secretariat Executive
- Dr. Tom Hudson, President and Scientific Director, Ontario Institute
of Cancer Research
When: Monday, January 26th, 2009 at 10:00 a.m.
Where: Princess Margaret Hospital
610 University Avenue
7th Floor Atrium
For further information: Media Contact: Lenore Bromley, Sr. Public
Affairs Advisor, Cancer Care Ontario, (416) 971-9800 ext. 3383,
lenore.bromley@cancercare.on.ca
